ER receptors are present in normal endometrial myometrium cells of the uterus in normal epithelial cells of the breast and in some breast cancer cells (about 50-60% of breast cancer patients).Researches have shown that ER positive breast cancer patients respond effectively to hormone therapy and have a better prognosis than the ER negative group.Therefore, ER, PR, and C-erbB-2 are used together to guide patient treatment.
[As Figure Shows]
Ovarian cancer tissue stained with ERG
ER receptors are present in normal endometrial myometrium cells of the uterus in normal epithelial cells of the breast and in some breast cancer cells (about 50-60% of breast cancer patients).Researches have shown that ER positive breast cancer patients respond effectively to hormone therapy and have a better prognosis than the ER negative group.Therefore, ER, PR, and C-erbB-2 are used together to guide patient treatment.
Product Name | Progesterone Receptor (C4D10),MMab |
Catalog No. | CEM-0081 |
Intended Use | IVD, RUO |
Species Reactivity | Human; others not tested |
Cellular Localization | Cytoplasm / Nucleus |
Antibody Type | Mouse Monoclonal |
Clone | C6H7 |
Format and Volume | Ready-to-use: 1mL, 3mL, 6mL Concentrated: 0.1mL, 0.2mL and 1mL |
IVD Datasheet (IFU) | ↕️ Download |
RUO Datasheet (IFU) | ↕️ Download |
SDS sheet | check with sales |
Store at 2~8°C. Avoid freezing.
Maintain temperature below room temperature during transport, ensuring it does not exceed one week.